Split cord malformations (SCMs) are rare spinal anomalies and their classification is still a matter of debate. There is no widespread consensus on the embryological basis of this entity. The unified theory, proposed by Pang et al. [Neurosurgery 1992;31:451–480], was an attempt to explain the embryogenetic mechanism as a basic error occurring around the time when the primitive neuroenteric canal closes. We report two unusual cases of SCMs with a dorsally situated bony spur. We analyzed the radiological, clinical and surgical features of the lesions and were not able to classify these cases according to the unified theory. Further embryological studies should be conducted to elucidate the mechanisms of occurrence of these lesions, and the dorsal bony septum variant should be considered in SCM surgery.

1.
Pang D, Dias MS, Ahab-Barmada M: Split cord malformation. 1. A unified theory of embryogenesis for double spinal cord malformations. Neurosurgery 1992;31:451–480.
2.
Pang D: Split cord malformation. 2. Clinical syndrome. Neurosurgery 1992;31:481–500.
3.
Chandra PS, Mahapatra RK: An unusual case of dorsally situated bony spur in a lumbar split cord malformation. Pediatr Neurosurg 1999;31:4–52.
4.
Erşahin Y: An unusual split cord malformation. Pediatr Neurosurg 2000;32:109.
5.
Ollivier CP: Traité des maladies de la moelle épinière. Paris, Mequignon-Marvis, 1837.
6.
Dias MS, Pang D: Split cord malformations. Neurosurg Clin N Am 1995;6:339–358.
7.
Erşahin Y, Mutluer S, Kocaman S, Demirtaş E: Split cord malformations in children. J Neurosurg 1998;88:57–65.
8.
Erşahin Y, Demirtaş E, Mutluer S, Tosun AR, Saydam S: Split cord malformations: Report of three unusual cases. Pediatr Neurosurg 1996;24:155–159.
9.
Emura T, Asashima M, Hashizume K: An experimental animal model of split cord malformation. Pediatr Neurosurg 2000;33:283–292.
10.
Katoh M, Hida K, Iwasaki Y, Koyanagi I, Abe H: A split cord malformation. Childs Nerv Syst 1998;14:398–400.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.